Screening for hypertrophic cardiomyopathy

被引：5

作者：

Pydah, Sunayana C. ^{[1
]}

Mauck, Kimberlee ^{[1
]}

Shultis, Chelsea ^{[1
]}

Rolfs, Jenna ^{[2
]}

Schmidt, Eric

Nicholas, Joyce

机构：

[1] Univ Lynchburg, PA Program, Lynchburg, VA 24501 USA

[2] Free Clin Cent Virginia, Lynchburg, VA USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2021年 / 34卷 / 10期

关键词：

hypertrophic cardiomyopathy; inherited; cardiac disease; left ventricular hypertrophy; sudden cardiac death; screening; MEDICAL-MANAGEMENT; HEART-ASSOCIATION; TASK-FORCE; DIAGNOSIS; DISEASE; GENETICS;

D O I：

10.1097/01.JAA.0000791464.54226.d8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and causes changes in the cardiac muscle affecting ventricular, valvular, and cellular functions. Because HCM is an inherited disorder, all age groups are affected; however, it commonly presents in adolescents, especially athletes. Many patients are asymptomatic and undiagnosed, putting them at risk for sudden cardiac death. This article describes screening and management of patients with HCM.

引用

页码：23 / 27

页数：5

共 50 条

[21] Hypertrophic cardiomyopathy
Santos Mateo, Juan Jose
Sabater Molina, Maria
Gimeno Blanes, Juan Ramon
MEDICINA CLINICA, 2018, 150 (11): : 434 - 442
[22] Hypertrophic cardiomyopathy
Kuehl, Constantin
Frey, Norbert
MEDIZINISCHE GENETIK, 2017, 29 (03) : 316 - 322
[23] Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy
van Velzen, Hannah G.
Schinkel, Arend F. L.
Baart, Sara J.
Oldenburg, Rogier A.
Frohn-Mulder, Ingrid M. E.
van Slegtenhorst, Marjon A.
Michels, Michelle
CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (04): : e001896
[24] Hypertrophic cardiomyopathy
Scheffold, T
Binner, P
Erdmann, J
Schunkert, H
HERZ, 2005, 30 (06) : 550 - 557
[25] Hypertrophic Cardiomyopathy
Geske, Jeffrey B.
Ommen, Steve R.
Gersh, Bernard J.
JACC-HEART FAILURE, 2018, 6 (05) : 364 - 375
[26] To Screen or Not to Screen, That Is the Question When to Start Screening Families With Hypertrophic Cardiomyopathy
Mital, Seema
Ommen, Steve
CIRCULATION, 2019, 140 (03) : 193 - 195
[27] Family screening in hypertrophic cardiomyopathy is underperformed, but can be improved by a specialised clinic
Olaussen, A.
Beale, A.
Macciocca, I.
Ellims, A. H.
INTERNAL MEDICINE JOURNAL, 2014, 44 (07) : 665 - 670
[28] Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance
Huurman, Roy
van der Velde, Nikki
Schinkel, Arend F. L.
Hassing, H. Carlijne
Budde, Ricardo P. J.
van Slegtenhorst, Marjon A.
Verhagen, Judith Ma
Hirsch, Alexander
Michels, Michelle
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2022, 23 (09) : 1144 - 1154
[29] Genetic Testing in Patients with Hypertrophic Cardiomyopathy
Bonaventura, Jiri
Polakova, Eva
Vejtasova, Veronika
Veselka, Josef
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
[30] Hypertrophic Cardiomyopathy: Infants, Children, and Adolescents
Maskatia, Shiraz A.
CONGENITAL HEART DISEASE, 2012, 7 (01) : 84 - 92

← 1 2 3 4 5 →